Skip to main content

TrialNet: Pathway to Prevention Study – Screening

Pathway to Prevention screening is the first step for all TrialNet prevention studies. Screening is offered at no cost to eligible individuals to evaluate their personal risk of developing type 1 diabetes (T1D). This unique screening can identify the early stages of T1D years before any symptoms appear. It also helps researchers learn more about how T1D develops and plan new studies exploring ways to prevent it. Screening is offered to family members of people with T1D.

Sponsor

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and Juvenile Diabetes Research Foundation(JDRF)

Principle Investigator

Diane Wherrett

Researchers

  • Maha Rahman
  • Rylie Mitchell
  • Nilina Mohabir

Recruiting time left

Days
:
Hours
:
Minutes
:
Seconds

Contribute

Participating in research not only gives you access to innovative treatments, but also allows you to contribute to the discovery of new therapies.

SIGN UP

Commitment

1

Visits

30-45 mins

Duration

N/A

Frequency

Locations

Home Visit

Home visits bring the study straight to the participant’s home for their convenience.

In-Clinic

This indicates a physical location that participants would be required to travel to for the study activities.

Clinics

SIGN UP
< View All Studies